ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
HORIZON KINETICS MEDICAL ETF
34.96
-0.3314
-0.94%
盤後：
35.04
0.0823
+0.24%
16:10 EDT
成交量：
588
成交額：
2.06萬
市值：
1,642.82萬
市盈率：
- -
高：
35.04
開：
34.99
低：
34.96
收：
35.29
52周最高：
37.90
52周最低：
28.87
股本：
46.99萬
流通股本：
46.99萬
量比：
0.27
換手率：
0.13%
股息：
0.41
股息率：
1.17%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。
智通财经
·
09/14
創新藥企赴港IPO提速 小分子創新藥成主力賽道
经济参考报
·
09/14
華泰證券：港股基本面與貼現率賽跑 首選紅利及創新藥
智通财经
·
09/13
B7-H3靶點ADC全球率先突破 世界肺癌大會迎來中國時刻
中国新闻网
·
09/13
WCLC大會開幕！一文搞懂創新藥臨床指標
新浪基金
·
09/13
創新藥跌跌不休，什麼原因？華寶基金港股通創新藥ETF（520880）失守所有均線
新浪基金
·
09/13
情緒冰點，A股單周成交額創年內新低！有色領跌，創新藥不振！關注華寶基金創業板人工智能ETF
新浪基金
·
09/13
從「產品出海」到「體系出海」，上海創新藥企復宏漢霖加速全球佈局
上观新闻
·
09/13
強生據報與阿波羅洽談約200億美元骨科業務交易
环球市场播报
·
09/13
邕寧區企業參與項目榮獲廣西科學技術進步獎一等獎
邕宁发布
·
09/13
河北一醫院工作人員先後收受商業賄賂46次，單次最大涉案金額1658萬元，持續時間最長達11年，累計涉案金額1.84億元
大象新闻
·
09/13
凱利泰子公司艾迪爾涉商業賄賂：被列為「特別嚴重失信」企業，集採衝擊、渠道失控兩頭擠壓
蓝鲸财经
·
09/12
區委統戰部攜手九三學社開展基層公益義診 將優質醫療服務送到群眾家門口
市场资讯
·
09/12
傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務 潛在交易估值近200億美元
智通财经
·
09/12
據彭博社報導，阿波羅全球正就收購強生公司骨科業務部門進行談判
路透中文
·
09/12
據彭博社報道，阿波羅全球正就收購強生公司骨科業務部門進行談判
路透中文
·
09/12
據稱阿波羅正在洽談收購強生骨科業務部門。
智通财经
·
09/12
禮來完成對Ataibeckley收購，加速推進難治性抑鬱症及其他精神健康疾病療法研發
美股速递
·
09/11
創新藥將迎數據催化窗口！OS、PFS、ORR還都分不清楚？速查指南來了！收藏備用
新浪基金
·
09/11
重磅大會在前，創新藥未有起色，什麼情況？華寶基金港股通創新藥ETF（520880）失守所有均線
新浪基金
·
09/11
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/MEDX/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9577,"timestamp":1789502400000,"preClose":35.2891,"halted":0,"volume":588,"hourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"delay":0,"changeRate":-0.009391001754082565,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"未開盤","change":-0.3314,"latestTime":"09-15 16:00:00 EDT","open":34.99,"high":35.04,"low":34.9577,"amount":20606,"amplitude":0.002332,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":35.2891,"sharesOutstanding":569946,"nav":35.26,"aum":16570295.96,"dividendRate":0.0117,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"volumeRatio":0.26793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.26793,"shares":469946,"dividePrice":0.409,"high":35.04,"amplitude":0.002332,"preClose":35.2891,"low":34.9577,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9577,"eps":0,"divideRate":0.0117,"volume":588,"delay":0,"ttmEps":0,"open":34.99,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.4213,"twentyDayClose":35.8903,"sixtyDayClose":33.8763},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667631840","title":"強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631840?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:46","pubTimestamp":1789350398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BGHQF631.EUR","LU2471134523.USD","LU0053666078.USD","LU1145028129.USD","PJP","BK4588","FTXH","IE00BVYPNV92.GBP","LU2592432038.USD","GDOC","BK4568","IE0001KFT4U8.USD","BMED","LU0683600562.USD","VHT","IE0002141913.USD","LU2471134879.HKD","LU2133065610.SGD","LU0426417589.USD","LU0072461881.USD","IHE","BK4533","IE00B3T34201.USD","LU1280957306.USD","LU1674673691.USD","LU0820561909.HKD","IE00BLSP4239.USD","IYH","LU1032466523.USD","LU1935042991.SGD","MEDX","FHLC","IXJ","LU2430703095.HKD","TRUH","LU0511384066.AUD","LU1894683264.USD","XLV","JDOC","IE0000B7K699.USD","RXL","IE00BFTCPJ56.SGD","IE00BDGV0183.EUR","LU0985320562.USD","LU1244550494.USD","LU2089984988.USD","BK4550","LU0122379950.USD","BK4559","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635798","title":"創新藥企赴港IPO提速 小分子創新藥成主力賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635798","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635798?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 07:52","pubTimestamp":1789343542,"startTime":"0","endTime":"0","summary":"【创新药企赴港IPO提速 小分子创新药成主力赛道】8月下旬以来，征祥医药、益方生物、迪哲医药、贝达药业、维眸生物、诺令生物、普莱医药、信立泰等多家企业，密集向港交所递交上市申请，掀起新一轮本土创新药闯关港股18A板块的热潮。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1354,202609143872918250.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609143872918250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["BK1574","159992","LNGR","IBBQ","BK4127","IPOS","MEDX","06978","KCE","BK1161","FRHC","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667871386","title":"華泰證券：港股基本面與貼現率賽跑 首選紅利及創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2667871386","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667871386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 23:44","pubTimestamp":1789314266,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","KCAI","BK4588","IBBQ","BK4585","VXUS","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667682589","title":"B7-H3靶點ADC全球率先突破 世界肺癌大會迎來中國時刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2667682589","media":"中国新闻网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667682589?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 20:11","pubTimestamp":1789301465,"startTime":"0","endTime":"0","summary":"9月13日，韩国首尔，世界肺癌大会(WCLC)主席论坛。中山大学肿瘤防治中心张力教授分享了B7-H3抗体偶联药物依康坦博妥塔单抗(Tam-Peli，代号YL201)对比盐酸托泊替康用于治疗复发性小细胞肺癌的Ⅲ期注册研究TAISHAN-302成果，这是全球范围内以B7-H3为靶点的ADC首次公布Ⅲ期临床研究数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872861815.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872861815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KURE","IBBQ","BK1161","MEDX","LNGR","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667272684","title":"WCLC大會開幕！一文搞懂創新藥臨床指標","url":"https://stock-news.laohu8.com/highlight/detail?id=2667272684","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667272684?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 19:26","pubTimestamp":1789298760,"startTime":"0","endTime":"0","summary":"9月12日，2026年WCLC正式开幕，康方生物、石药集团、科伦博泰生物等诸多创新药龙头公司公布旗下核心产品临床数据。FDA加速批准程序允许基于替代终点批准药物，但上市后需完成确证性试验。FDA规定，提交后30天内若无异议，IND自动生效。文中提及个股在恒生港股通创新药精选指数中的权重占比情况见配图。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-13/doc-inirsuvw4447257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","IBBQ","BK1161","06978","159992","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667684274","title":"創新藥跌跌不休，什麼原因？華寶基金港股通創新藥ETF（520880）失守所有均線","url":"https://stock-news.laohu8.com/highlight/detail?id=2667684274","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667684274?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 19:25","pubTimestamp":1789298700,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线，重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图：港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整？低位埋伏创新药，关注两大投资工具：港股通创新药ETF华宝：紧密跟踪恒生港股通创新药精选指数，100%布局创新药研发类公司，前十大权重股占比超七成，龙头属性突出，底层资产是港股，高弹性、T+0。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-13/doc-inirsuvy5397470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","BK1574","FLHK","159316","520880","BK1161","MEDX","06978","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667684278","title":"情緒冰點，A股單周成交額創年內新低！有色領跌，創新藥不振！關注華寶基金創業板人工智能ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2667684278","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667684278?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 19:24","pubTimestamp":1789298640,"startTime":"0","endTime":"0","summary":"本周，A股主要指数整体承压、多数收跌，创指逆市上涨1.08%一枝独秀，市场显著缩量，累计成交9.46万亿元，创年内单周地量，短期情绪或触冰点。资金关注高“光”指数布局机会，创业板人工智能ETF华宝场内热度高企，标的指数日内“V”型拉升。该规则已于7月22日通过，拟于9月11日在联邦公报正式刊载，30日后正式生效。三重因素扰动，有色ETF跳空下跌！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-13/doc-inirsuvw4446663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["TECY","LCLG","QTOC","399006","MEDX","MVPS","000001.SH","CWC","399300","LNGR","NBDS","NEWZ","GK","159992","ARTY","06978","510300","IBBQ","OGIG","TARK","159915","FDN","AIBU","159967","WPAI","159876","AIFD","000688.SH","PBOT","QQA","CNXT","000300.SH","161631","FWD","VUSE","510880","AIQU","03188","159982","CHAT","DQJN","512510","QSWN","KOMP","MFIG","AGIX","AQGX","QID","CPNQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667681787","title":"從「產品出海」到「體系出海」，上海創新藥企復宏漢霖加速全球佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2667681787","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667681787?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 17:19","pubTimestamp":1789291195,"startTime":"0","endTime":"0","summary":"日前，上海创新药企复宏汉霖举办2026年开放日活动，围绕全球化布局、生物类似药商业化、创新研发及临床开发等话题披露最新进展。复宏汉霖执行董事、首席执行官朱俊博士介绍，截至目前，复宏汉霖已有4款产品获美国食品药品监督管理局（FDA）批准、5款获欧盟（EC）批准、8款获中国国家药品监督管理局（NMPA）批准，产品已惠及全球超过110万名患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872844911.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872844911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LNGR","BK1574","IBBQ","HK0000165453.HKD","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","HK0000306701.USD","BK1161","159992","06978","MEDX","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667329689","title":"強生據報與阿波羅洽談約200億美元骨科業務交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667329689","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667329689?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 14:27","pubTimestamp":1789280820,"startTime":"0","endTime":"0","summary":"据知情人士消息，阿波罗全球管理公司正洽谈收购强生旗下以DePuy Synthes为主体的骨科业务，交易金额约为200亿美元。知情人士称，强生与阿波罗正在就出售展开谈判，但双方仍可能无法达成交易，强生也可能选择其他买家。强生和阿波罗目前均未公布交易安排。以当前报道的约200亿美元交易金额计算，潜在售价与强生当年的实际收购价格大致相当，但期间业务范围、财务表现和资产构成已经发生变化。此次潜在出售也是强生持续调整业务组合的一部分。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-13/doc-inirskha4546532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VHT","LU2456880835.USD","TRUH","LU1228905540.USD","LU2023250330.USD","IE000F7OJYX1.SGD","IYH","LU0122379950.USD","IE00B19Z3581.USD","LU1496350502.SGD","LU0889566641.SGD","LU0640476718.USD","PJP","IE0009355771.USD","LU0792757196.USD","LU0426412945.USD","BMED","LU1778281490.HKD","FTXH","IE00B42XCP33.USD","IE00B4R5TH58.HKD","JNJ","IE00BVYPNV92.GBP","LU2089984988.USD","LU0795875169.SGD","LU1066053197.SGD","LU1732800096.USD","LU2430703251.USD","LU1935042991.SGD","RXL","GDOC","IXJ","LU0689472784.USD","LU0795875086.SGD","LU0545562505.USD","XLV","IE00BFXG1179.USD","LU2896262040.SGD","IHE","LU1074936037.SGD","LU2471134523.USD","LU2129689431.USD","MEDX","LU1059921491.USD","LU1430594728.SGD","LU2213496289.HKD","JDOC","LU0057025933.USD","FHLC","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667685237","title":"邕寧區企業參與項目榮獲廣西科學技術進步獎一等獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2667685237","media":"邕宁发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667685237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:07","pubTimestamp":1789268820,"startTime":"0","endTime":"0","summary":"近日，在广西科学技术奖励评选中，由广西医科大学第一附属医院曹存巍教授牵头，广西鹤兰墨广泽生物科技有限公司协同参与的“广西（东盟）重大真菌病精准诊疗与防控关键技术集成及产业化”项目，荣获广西科学技术进步奖一等奖。此次殊荣的获得，是广西鹤兰墨广泽生物科技有限公司长期坚持产学研深度融合发展的成果体现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-13/doc-inirrxsc0620132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGNG","HBImain","GDOC","IBBJ","LNGR","MEDX","SYNB","IEIH","BK4585","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667683005","title":"河北一醫院工作人員先後收受商業賄賂46次，單次最大涉案金額1658萬元，持續時間最長達11年，累計涉案金額1.84億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667683005","media":"大象新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667683005?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 09:18","pubTimestamp":1789262280,"startTime":"0","endTime":"0","summary":"继上海某科贸商行涉支架球囊行贿案公开曝光河北医科大学第二医院“每条支架收5000元回扣”后，仅2025年下半年，该院又涉及9件司法刑事判决。该医院工作人员先后收受商业贿赂46次，单次最大涉案金额1658万元，持续时间最长达11年，累计涉案金额1.84亿元。分析发现，超过30家医药企业长期对该医院工作人员行贿。河北祥恩医疗器械贸易有限公司为向河北医科大学第二医院销售价格虚高的医疗耗材，累计向该医院工作人员行贿2064万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-13/doc-inirrtkk4766738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDEV","09996","09939","AGNG","BK1515","BK1574","PTH","RSPH","BK1161","GDOC","BK1583","BK1100","MEDX","LGHT","LNGR","IEIH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666504386","title":"凱利泰子公司艾迪爾涉商業賄賂：被列為「特別嚴重失信」企業，集採衝擊、渠道失控兩頭擠壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2666504386","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666504386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 21:10","pubTimestamp":1789218656,"startTime":"0","endTime":"0","summary":"蓝鲸新闻向凯利泰方面求证具体涉案信息，截至发稿尚未收到回复。通过检索公开权威信息发现，除了此次事件，近年来，艾迪尔屡次被曝涉嫌商业贿赂。艾迪尔母公司凯利泰同样多次涉及商业贿赂事件。因为一旦被评定为“特别严重失信”，很可能会失去医保报销市场，对企业发展会带来巨大冲击。不过目前来看，作为名单中7家被评为“特别严重失信”的企业之一，艾迪尔尚未发表致歉声明。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789198644422913532","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LGHT","HART","09996","IEIH","BK0251","BK1574","BK1583","LNGR","MEDX","300326","PTH","MDEV","BK1100","RSPH","GDOC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666503118","title":"區委統戰部攜手九三學社開展基層公益義診 將優質醫療服務送到群眾家門口","url":"https://stock-news.laohu8.com/highlight/detail?id=2666503118","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666503118?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 11:56","pubTimestamp":1789185360,"startTime":"0","endTime":"0","summary":"9月12日上午，区委统战部携手九三学社呼兰区联合支社，走进呼兰区腰堡社区卫生服务中心开展公益义诊惠民活动。活动紧扣基层群众就医实际需求，将专业医疗资源下沉到社区一线，以实际行动践行为民服务宗旨，把健康服务直接送到居民家门口。区委统战部副部长姜贵文，九三学社呼兰区联合支社主委王婧出席活动。区委统战部充分发挥统一战线资源优势，积极协调对接，为此次公益义诊活动的顺利开展提供了有力保障。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-12/doc-inirputk6718397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666508051","title":"傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務 潛在交易估值近200億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666508051","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666508051?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 11:04","pubTimestamp":1789182275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体援引知情人士消息报道，全球另类资产管理公司阿波罗全球管理 正洽谈收购强生的骨科业务部门DePuy Synthes。这笔交易对该业务的估值可能接近200亿美元。强生的骨科业务部门DePuy Synthes主要生产关节植入物和手术器械，2025年创造了93亿美元的收入，但收入增速仅为1.1%。相比之下，强生2025年整体营收同比增长6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GPZ","JDOC","LU1057294990.SGD","LU1506573853.SGD","BK4585","IE00B3T34201.USD","BMED","LU2129689431.USD","VHT","LU0545562505.USD","LU0689626769.HKD","JNJ","IE00B42XCP33.USD","PRVT","LU2468319806.SGD","MEDX","AAUM","LBO","IHE","LU2487616109.SGD","LU0345769631.USD","LU0006061336.USD","LU2112291526.USD","FHLC","LU1244550494.USD","IXJ","LU2471134523.USD","APO","LU2756315318.SGD","LU2471134796.USD","FTXH","IE000F7OJYX1.SGD","LU2602419157.SGD","LU1989771016.USD","XLV","TRUH","GDOC","IE000BZT7R73.USD","PJP","IE00B775SV38.USD","LU0912757837.SGD","IYH","LU1162221912.USD","RXL","LU1267930813.SGD","LU1668664300.SGD","LU1032466523.USD","IE00BGHQF631.EUR","LU1066051498.USD","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666778075","title":"據彭博社報導，阿波羅全球正就收購強生公司骨科業務部門進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2666778075","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666778075?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166537,"startTime":"0","endTime":"0","summary":"据彭博社报导，阿波罗全球正就收购强生公司骨科业务部门进行谈判路透9月11日-据彭博社周五援引消息人士报导，阿波罗全球管理公司（Apollo Global Management，APO.N）正在就收购强生公司（Johnson & JohnsonJNJ.N）旗下骨科业务部门进行磋商，该交易可能使该业务部门的估值接近200亿美元。路透无法立即核实该报导。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4T4531JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1778281490.HKD","LU0795875086.SGD","IE00BGHQF631.EUR","LU2471134523.USD","LU2112291526.USD","LU0985320562.USD","LU0203347892.USD","IHE","LU1066051498.USD","RXL","JNJ","LBO","LU1585245621.USD","IXJ","LU0234572021.USD","LU1430594728.SGD","APO","FTXH","LU1228905540.USD","BK4592","IE00BVYPNW00.USD","JDOC","LU2347655156.SGD","PRVT","LU0345770993.USD","LU2487616109.SGD","LU0122379950.USD","BMED","IE00BSNM7G36.USD","BK4588","LU1551013342.USD","IYH","LU2129689514.USD","VHT","LU1668664300.SGD","LU2750360641.GBP","GPZ","LU1323610961.USD","GDOC","MEDX","FHLC","TRUH","LU1032955483.USD","LU1221951046.USD","PJP","LU1929549753.HKD","AAUM","LU0114720955.EUR","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577802","title":"據彭博社報道，阿波羅全球正就收購強生公司骨科業務部門進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577802","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577802?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166537,"startTime":"0","endTime":"0","summary":"据彭博社报道，阿波罗全球正就收购强生公司骨科业务部门进行谈判路透9月11日-据彭博社周五援引消息人士报道，阿波罗全球管理公司（Apollo Global Management，APO.N）正在就收购强生公司（Johnson & JohnsonJNJ.N）旗下骨科业务部门进行磋商，该交易可能使该业务部门的估值接近200亿美元。路透无法立即核实该报道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4S4531JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU0820562030.AUD","LU0964807845.USD","LU1043141396.HKD","GDOC","MEDX","IYH","IXJ","JNJ","SG9999001176.USD","LU0234570918.USD","IE00BGHQF631.EUR","LU1935042991.SGD","LU2112291526.USD","LU1629891620.HKD","LU1506573853.SGD","LU1261432733.SGD","LU1894683264.USD","LU0882574055.USD","LU2756315664.SGD","IHE","LU1228905540.USD","APO","BK4504","BMED","IE000MB6IJN5.SGD","VHT","LU1221951129.SGD","LU2505996509.AUD","LU0203345920.USD","RXL","XLV","IE000M9KFDE8.USD","LU1989771016.USD","LBO","LU1196500208.SGD","TRUH","PRVT","BK4007","IE000F7OJYX1.SGD","IE00BFXG1179.USD","BK4585","JDOC","PJP","GPZ","IE00BKVL7J92.USD","LU0792757196.USD","FTXH","LU1059921491.USD","AAUM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657206","title":"據稱阿波羅正在洽談收購強生骨科業務部門。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SGXZ80539844.SGD","TRUH","LU2750360997.AUD","IE00BFXG1179.USD","IYH","LU0345770308.USD","IE0000B7K699.USD","LU0210536198.USD","LU0795875086.SGD","LU0943347566.SGD","FHLC","LU0964807845.USD","LU1221951046.USD","VHT","JDOC","SGXZ57979304.SGD","IE00B1BXHZ80.USD","IHE","LU0640476718.USD","LU2468319806.SGD","LU1057294990.SGD","LU0289739699.SGD","IE000SO60NU8.SGD","LU2756315664.SGD","XLV","IXJ","LU2487616109.SGD","LU1066051498.USD","LU0345770993.USD","LU2133065610.SGD","LU1244550221.USD","IE000WAW04H5.SGD","LU1732800096.USD","BMED","LU0689472784.USD","LU2213496289.HKD","LU0820562030.AUD","LU0985320562.USD","RXL","JNJ","GDOC","PJP","SG9999001440.SGD","MEDX","SG9999001176.USD","FTXH","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU0787776722.HKD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154710349","title":"禮來完成對Ataibeckley收購，加速推進難治性抑鬱症及其他精神健康疾病療法研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1154710349","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154710349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 21:04","pubTimestamp":1789131857,"startTime":"0","endTime":"0","summary":"礼来公司已正式完成对Ataibeckley的收购事宜。这一战略举措，旨在为那些饱受难治性抑郁症以及其他精神健康疾病困扰的患者，开辟全新的治疗路径。此项交易的落定，标志着礼来在精神健康领域的布局迈出了坚实一步。礼来此番动作，显然意在突破这一瓶颈。通过将Ataibeckley的研发资产与专业团队纳入麾下，礼来有望整合各方资源，加速相关候选药物的研发进程。礼来此举，无疑将为其在精神科药物市场的未来竞争增添重要砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","BK4581","LU1979441026.SGD","LU2237443549.SGD","LU1323610961.USD","LU1804176565.USD","SG9999018865.SGD","LU0385154629.USD","LU2552382215.SGD","LU0787776722.HKD","LU2896262040.SGD","LU0820561818.USD","IE00BFSS7M15.SGD","LU2089984988.USD","ILDR","LU0210536198.USD","LU0943347566.SGD","LU2417539215.USD","IE00BJLML261.HKD","LU0079474960.USD","LU2063271972.USD","LU2023251221.USD","LU1623119135.USD","THNR","LU1551013425.SGD","LU0353189680.USD","LU2361044865.SGD","LU2264538146.SGD","LU2168564495.EUR","SG9999014906.USD","LU0320765992.SGD","LU2237443622.USD","LU0106261372.USD","LU2602419157.SGD","LU2552382132.HKD","TMED","LU2357305700.SGD","SGXZ99366536.SGD","WDNA","LU0786609619.USD","IE00BN29S564.USD","LU1267930730.SGD","SGXZ57979304.SGD","SG9999018857.SGD","LU0316494557.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU2756315664.SGD","LU0354030511.USD","SG9999014914.USD","BK4585","LU2324357040.USD","SG9999014880.SGD","BK4599","LU2471134796.USD","JDOC","MEDI","LLYZ","LU2265009873.SGD","LU2491049909.HKD","LU0158827781.USD","IE00B4R5TH58.HKD","LU2028103732.USD","LU2111349929.HKD","SG9999017495.SGD","IE00B775H168.HKD","LU2750360641.GBP","BK4516","LU2108987350.USD","LU2461242641.AUD","LU0417517546.SGD","LU2168564149.EUR","LU2087625088.SGD","TRUH","LU0354030438.USD","RXL","LU0820562030.AUD","LLII","LU0889565916.HKD","LU1064131342.USD","LLY","LU2168564222.USD","LU0345770308.USD","LU2023250330.USD","LU2491050071.SGD","LU2462591350.SGD","LU1868836591.USD","LU2089283258.USD","LU1720051108.HKD","LU1232071149.USD","IE00B2B36J28.USD","LU1629891620.HKD","IE0001KFT4U8.USD","LU0061475181.USD","LU2462157665.USD","IE0004445239.USD","LU0006306889.USD","LU2237443382.USD","MHIP","OZEM","LU2237438978.USD","IE00B1XK9C88.USD","LU1720051017.SGD","SG9999015952.SGD","LU2491050154.USD","IE00B7KXQ091.USD","LU0471298694.HKD","SGXZ31699556.SGD","LU1057294990.SGD","IE00BWXC8680.SGD","CANC","LU0158827948.USD","LU1093756325.SGD","LU1127390331.HKD","LU1366192091.USD","SG9999013999.USD","LU2213496289.HKD","ELIS","LU1983299246.USD","LU1917777945.USD","LU1814569148.SGD","LU1069344957.HKD","LU1868837136.USD","IE00BKPKM429.USD","XLV","AGNG","LU2237443978.SGD","LU0432979614.USD","LU1691799644.USD","LU2023250504.SGD","BK4588","BK4534","LU2271345857.HKD","IYH","LLYX","LU1023059063.AUD","LU2211815571.USD","LU1548497426.USD","IE0009355771.USD","LU1712237335.SGD","LU2361045086.USD","LU0823434583.USD","LU1988902786.USD","CURE","IE00BJJMRZ35.SGD","LU0256863811.USD","LU0689472784.USD","LU2746668461.USD","LU0203201768.USD","LU2168564065.EUR","LU0096364046.USD","LU2168563687.JPY","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","BK4007","LU0234572021.USD","VHT","LU0097036916.USD","LU2237443895.HKD","LU0471298777.SGD","LU2756315318.SGD","LU0109394709.USD","LU1974910355.USD","SG9999001176.SGD","LU0672654240.SGD","LU0823434740.USD","LU0266013472.USD","IE0005OL40V9.USD","SG9999015978.USD","LU2456880835.USD","ELIL","IXJ","LU2106854487.HKD","LU2471134523.USD","BK4533","LU0323591593.USD","LU0820561909.HKD","LU2468319806.SGD","SGXZ51526630.SGD","SG9999001176.USD","LU0345770993.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU0203202063.USD","LU0964807845.USD","LU1280957306.USD","LU2746668974.SGD","LU0058720904.USD","LU0882574139.USD","LU1868837300.USD","LU1035775433.USD","LU2236285917.USD","LU0109391861.USD","IE00BJJMRY28.SGD","LU2471134879.HKD","LU0683600562.USD","LU1868836914.USD","LU1868836757.USD","PPH","IE00BFSS8Q28.SGD","PJP","IHE","LU0640476718.USD","LU0289739699.SGD","LU0225283273.USD","LU0174119429.USD","LU0456855351.SGD","LU2237443465.HKD","LU2361044949.HKD","LU1551013342.USD","LU0320765059.SGD","LU0882574055.USD","SGXZ81514606.USD","IE00B4JS1V06.HKD","LU0198837287.USD","LU0466842654.USD","IE00BJJMRX11.SGD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU0094547139.USD","LU1291159041.SGD","LU2750360997.AUD","SG9999014898.SGD","IE0004445015.USD","LU0133085943.USD","LU0823416689.USD","LU1989771016.USD","SG9999015986.USD","HRTS","GB00BDT5M118.USD","LU1061106388.HKD","LU2360106947.USD","FHLC","LU2552382058.USD","LU2471134952.CNY","LU1093756168.USD","LU2089284900.SGD","LU0353189763.USD","GDOC","FTXH","IE0002141913.USD","MEDX","LU0708995401.HKD","SG9999015945.SGD","LU2112291526.USD","LU1145028129.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666798529","title":"創新藥將迎數據催化窗口！OS、PFS、ORR還都分不清楚？速查指南來了！收藏備用","url":"https://stock-news.laohu8.com/highlight/detail?id=2666798529","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666798529?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125720,"startTime":"0","endTime":"0","summary":"创新药重磅提示！就在周六，2026年WCLC将正式开幕，康方生物、石药集团、科伦博泰生物等诸多创新药龙头公司将公布旗下核心产品临床数据。III期达到终点，意味着获批概率大幅提升，属于实质性大利好。临床试验中通常报告“中位OS”，即50%患者存活的时间。FDA加速批准程序允许基于替代终点批准药物，但上市后需完成确证性试验。FDA规定，提交后30天内若无异议，IND自动生效。以优效性为目标的头对头试验证据级别最高。权重数据截至2026.8.31。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrw8907408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","LNGR","06978","ORR","IBBQ","BK1574","MEDX","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529140","title":"重磅大會在前，創新藥未有起色，什麼情況？華寶基金港股通創新藥ETF（520880）失守所有均線","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529140","media":"新浪基金","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529140?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 19:17","pubTimestamp":1789125420,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线，重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图：港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整？低位埋伏创新药，关注两大投资工具：港股通创新药ETF华宝：紧密跟踪恒生港股通创新药精选指数，100%布局创新药研发类公司，前十大权重股占比超七成，龙头属性突出，底层资产是港股，高弹性、T+0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhry5675751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","FLHK","06978","IBBQ","159316","BK1574","BK1161","MEDX","520880","159992"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":5,"totalSize":259,"code":"91000000","status":"200"}]}}